Table 2 Physical status of HPV genome in cases and controls
From: Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins
| Â | Cases (%) | Controls (%) | Total number | P-value | |
|---|---|---|---|---|---|
Integrated | 30/35 (86%) | Â | 1/5 (20%) | 31/40 (77.5%) | 0.006 |
Stages: | Types: | Â | Â | Â | |
|  |  | Ductal (n = 11) |  |  |  |
I (n = 3) | Lobular (n = 4) |  |  |  | |
II (n = 3) | Medullary(n = 6) |  |  |  | |
III (n = 9) | Tubular (n = 5) |  |  |  | |
IV (n = 15) | Mucinous (n = 4) |  |  |  | |
Episomal | – | 4/5 (80%) | 4/40 (10%) | NA | |
Mixed | 5/35 (14%) |  | – | 5/40 (12.5%) | NA |
Stages: | Types: | Â | Â | Â | |
I (n = 3) | Ductal (n = 3) |  |  |  | |
II (n = 2) | Lobular (n = 0) |  |  |  | |
III (n = 0) | Medullary(n = 1) |  |  |  | |
IV (n = 0) | Tubular (n = 1) |  |  |  | |
Mucinous (n = 0) |  |  |  | ||